News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Orexo AB Converts Convertible Bonds Subscribed for by Novo A/S


8/26/2013 10:18:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: During the second quarter of 2010 Novo A/S subscribed for a convertible bond issue of MSEK 111 by Orexo AB. The bonds have a fixed rate coupon of 8 per cent per annum and a conversion price of SEK 47.50. When Orexo AB’s share price exceeds the conversion price by 50% during a certain period, Orexo AB has the right to convert the convertible bonds and accrued interest into shares. The conditions for conversion were met on August 23, 2013 and Orexo AB then resolved to exercise its right to convert. Pursuant to the conditions for the bonds, not only the principal is converted at the time of conversion, but also unpaid accrued interest.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Orexo AB
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES